Alberto Martinez-Vea

Summary

Publications

  1. ncbi request reprint Role of oxidative stress in cardiovascular effects of anemia treatment with erythropoietin in predialysis patients with chronic kidney disease
    Alberto Martinez-Vea
    Nephrology Service, Hospital Universitari de Tarragona Joan XXIII, IISPV, Tortosa, Spain
    Clin Nephrol 77:171-81. 2012
  2. pmc Evaluation of oxidative stress biomarkers in patients with chronic renal failure: a case control study
    Marta Romeu
    Pharmacology Unit, Department of Basic Medical Sciences, Universitat Rovira i Virgili, Spain
    BMC Res Notes 3:20. 2010
  3. doi request reprint Cystatin C and cardiac hypertrophy in primary hypertension
    Merche Prats
    Nephrology Service, Hospital Universitari de Tarragona Joan XXIII, Mallafre Guasch 4, Tarragona 43007, Spain
    Blood Press 19:20-5. 2010
  4. ncbi request reprint Exercise blood pressure, cardiac structure, and diastolic function in young normotensive patients with polycystic kidney disease: a prehypertensive state
    Alberto Martinez-Vea
    Nephrology Service, Hospital Universitari de Tarragona Joan XXIII, Tarragona, Spain
    Am J Kidney Dis 44:216-23. 2004
  5. ncbi request reprint Silent cerebral white matter lesions and their relationship with vascular risk factors in middle-aged predialysis patients with CKD
    Alberto Martinez-Vea
    Nephrology Service, Institut de Diagnostic per la Imatge, Hospital Universitari de Tarragona Joan XXIII, Tarragona, Spain
    Am J Kidney Dis 47:241-50. 2006

Collaborators

  • Alfredo Bardaji
  • Marta Romeu
  • Merche Prats
  • Montserrat Giralt
  • Miquel Mulero
  • Jordi Mallol
  • Luis Marcas
  • Cristina Gutierrez
  • Vanesa S├ínchez-Martos
  • Ramon Font
  • Angels Vilanova
  • Marta Lalana
  • Rosa Nogues

Detail Information

Publications5

  1. ncbi request reprint Role of oxidative stress in cardiovascular effects of anemia treatment with erythropoietin in predialysis patients with chronic kidney disease
    Alberto Martinez-Vea
    Nephrology Service, Hospital Universitari de Tarragona Joan XXIII, IISPV, Tortosa, Spain
    Clin Nephrol 77:171-81. 2012
    ..We proposed to assess whether the pro-oxidant status of CKD influences these outcomes...
  2. pmc Evaluation of oxidative stress biomarkers in patients with chronic renal failure: a case control study
    Marta Romeu
    Pharmacology Unit, Department of Basic Medical Sciences, Universitat Rovira i Virgili, Spain
    BMC Res Notes 3:20. 2010
    ..The disequilibrium in the oxidant-antioxidant balance is the result of several metabolic changes. The majority of studies to-date have evaluated the grade of oxidative stress with a single biomarker, or a very limited number of them...
  3. doi request reprint Cystatin C and cardiac hypertrophy in primary hypertension
    Merche Prats
    Nephrology Service, Hospital Universitari de Tarragona Joan XXIII, Mallafre Guasch 4, Tarragona 43007, Spain
    Blood Press 19:20-5. 2010
    ..Cystatin C is a marker of kidney function and a predictor of cardiovascular morbidity and mortality. It is unknown whether this protein may be related to the cardiac involvement that is common among patients with essential hypertension...
  4. ncbi request reprint Exercise blood pressure, cardiac structure, and diastolic function in young normotensive patients with polycystic kidney disease: a prehypertensive state
    Alberto Martinez-Vea
    Nephrology Service, Hospital Universitari de Tarragona Joan XXIII, Tarragona, Spain
    Am J Kidney Dis 44:216-23. 2004
    ..The aim of this study is to evaluate blood pressure (BP) response to exercise and very early alterations in cardiac structure and diastolic function in young normotensive patients with ADPKD...
  5. ncbi request reprint Silent cerebral white matter lesions and their relationship with vascular risk factors in middle-aged predialysis patients with CKD
    Alberto Martinez-Vea
    Nephrology Service, Institut de Diagnostic per la Imatge, Hospital Universitari de Tarragona Joan XXIII, Tarragona, Spain
    Am J Kidney Dis 47:241-50. 2006
    ..No data on the prevalence and risk factors of white matter lesions in patients with chronic kidney disease (CKD) are available. The aim is to analyze the prevalence of white matter lesions and their determinants in this population...